Compare Quest Diagnostics Inc (DGX) vs Lufax Holding Ltd (LU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Quest Diagnostics Inc vs Lufax Holding Ltd — how do they compare? Quest Diagnostics Inc trades at $231.73 (market cap $25.48B), while Lufax Holding Ltd trades at $0.95 (market cap $982.89M). The key difference: Quest Diagnostics Inc is far larger — about 25.9× Lufax Holding Ltd's market cap, and Quest Diagnostics Inc pays a 1.49% dividend while Lufax Holding Ltd pays none. Which is the better fit depends on your goals — on Pluang, investors hold Quest Diagnostics Inc for 56 Days and Lufax Holding Ltd for 13 Days on average.
| DGX | LU | |
|---|---|---|
Market Cap | $25.48B | $982.89M |
Volume | 941,866 | 3,323,384 |
Sector | Health | Financials |
52-Week High | $247.45 | $3.93 |
52-Week Low | $173.49 | $0.95 |
Typical Hold Time | 56 Days | 13 Days |
Enterprise Value | $31.23B | $58.81B |
Dividend Yield | 1.49% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Quest Diagnostics (DGX) trades at $227.00, down 0.64% on the day, with the stock showing strong fundamental performance including three consecutive quarterly earnings beats and revenue growth from $9.9B in 2024 to $11.04B in 2025. Technical indicators signal bearish momentum with the current price near key support at $226, while the company maintains solid profitability with 9.19% net income margin and 14.35% ROE. Recent developments include positive clinical study results and a new partnership with Apple Health app for lab testing integration.
The investment outlook remains positive with analyst consensus target of $250 representing 10% upside potential, though Medicare reimbursement cuts pose near-term headwinds. Growth drivers include advanced diagnostics expansion and consumer testing demand, balanced against technical weakness and regulatory uncertainty. The stock offers value with reasonable P/E of 24.1 and consistent dividend payments.
LU trades at $0.9814, down 2.83% on the day, with a bearish technical signal from moving averages but a bullish signal from oscillators. The company reported a net loss of $2.10 billion on revenue of $23.11 billion in 2025, with negative profit margins and ROE. A 10:1 reverse stock split was implemented on October 23, 2026, and recent news highlights ongoing restructuring and regulatory challenges in China's consumer lending market.
The outlook remains challenging due to persistent losses and revenue declines, but deep value is suggested by a low P/B of 0.07 and significant analyst buy ratings (69%). Key risks include regulatory tightening and liquidity shocks in China, while potential catalysts include balance sheet strength and operational improvements under parent company Ping An's backing.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →About Lufax Holding Ltd
Lufax Holding Ltd is a leading financial technology (fintech) platform in China. The company operates a technology-driven personal financial services platform that offers a wide range of loans and wealth management products to its users. Lufax primarily serves the rapidly growing wealth and consumption needs of China’s mass affluent and affluent populations through a combination of its digital platform and an extensive offline network.
Read more on LU →
